Two mRNA vaccines are leading the race to quell the pandemic, with viral-vector and other vaccine platforms following close behind. This month’s feature takes a look at the data so far—and some questions that remain.
The April CME supplement from MedEdicus can be found here: ReNewed Sensation: Improving Awareness, Diagnosis, and Treatment of Neurotrophic Keratitis.
|